Navigation Links
New IBM Study Highlights Analytics as Top Priority for Today's CIO
Date:9/10/2009

g a strongly centralized infrastructure in the next five years. Furthermore, more than half of CIOs are expecting to implement completely standardized, low-cost business processes.
  • Even as they build these standardized low-cost infrastructures, CIOs are able to focus 55 percent of their time on activities that drive innovation and growth, whereas traditional IT tasks like infrastructure and operations management now consume only 45 percent of their time.

    • "CIOs are investing in business analytics capabilities to help them improve decision-making at all levels," said Pat Toole, CIO of IBM. "In addition, in this challenging economy, CIOs understand that analytics can be key to new growth markets, whether it's new ways to manage a utility grid or smarter healthcare systems. Managing and leveraging new intelligence through analytics is something that today's CIO is pursuing to gain competitive advantage in these new markets."

    "This study is a very important piece of work. The duality of the role of the CIO - to be both a visionary and a pragmatist, value creator and a cost cutter - is an issue I and most of the CIOs I talk to deal with every day," said Melodie Mayberry-Stewart, CIO and director of the Office for Technology, The Office of the New York State CIO/Office for Technology. "The fact that over 2,500 of my fellow CIOs shared their hopes, challenges and insights is helpful to me as I assess where I need to be professionally as a CIO and where my executive team needs to aspire to as part of my succession planning. I view this new Study as a great opportunity and challenge for my team to transform how we do business in the state of New York."

    As the role of the CIO itself transforms so do the types of projects they lead across their enterprises, which will allow CIOs to focus less time and resources on running internal infrastructure, and more time on transformation to help their
    '/>"/>

    SOURCE IBM Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine news :

    1. New Study a 'Wake Up Call' For the Urgent Need for Sleep Apnea Treatment
    2. Childrens Hospital receives federal contract to study antibiotic use in children with UTIs
    3. Study Shows 1% of Americans Have Been Infected With West Nile
    4. Queens study to test Canadian guidelines for daily exercise
    5. IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity
    6. Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs
    7. Nicotine Plays Tricks on Brain: Study
    8. Study reveals new role of vitamin C in skin protection
    9. Major clinical study rejects cancer safety fears of most common heartburn treatment
    10. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
    11. Study: Hairstylists can help identify older clients who need health services
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/14/2009)... AQUALIPO™ and NaturalFill™ revolutionary new liposuction and fat transfer treatments ... lips all in one minimally invasive treatment. , ... ... of AQUALIPO™ and NaturalFill™ can remove excess fat from the ... help people slim down, reduce facial wrinkling and enhance lips ...
    (Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
    (Date:12/14/2009)... -- Heska Corporation (Nasdaq: HSKA ; ... of veterinary diagnostic and specialty products, today ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer ... ) ,, Customers receiving these analyzers have ... analyzer available to the veterinary in-clinic market. ...
    (Date:12/14/2009)... Incorporated announced today that it has priced $400 ... a coupon of 6.9%. The notes will be ... 6.984%. The company anticipates using the proceeds from ... purposes. ,, Commenting on the pricing of the ... Officer Kriss Cloninger III commented: "This debt issuance ...
    (Date:12/14/2009)... Dental Care (also known as Culver City Dentist ... care in Southern California. We provide treatments in general ... and periodontal treatments. Beverly Hills Dentist and ... with experienced and trusted dentists who provide these treatments ... is one of these trusted dentists. He is best ...
    Breaking Medicine News(10 mins):Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3
    ... Sydney and Boston believe they may have identified a gene ... very troublesome problem for people with diabetes. , The liver ... sugar (glucose) levels fall, the liver makes and releases more. ... doesn,t stop making sugar when it should, so blood sugar ...
    ... and Efficacy Study of Zolpidem Tartrate Sublingual ... As-Needed BasisEvaluation of Ondansetron Augmentation in the ... 21 Transcept Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of ...
    ... ST. PETERSBURG, Fla., May 21 Mosaica Partners ... the Health Information Technology for Economic and Clinical ... healthcare through health information exchange (HIE) in its ... the Economic Stimulus Package for Health Information Exchange." ...
    ... Patients with Challenging Anatomy Consistent with Superior Results ... New data presented today at EuroPCR from an ... XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated ... stent thrombosis and major adverse cardiac events (MACE) ...
    ... assisted reproductive technology should be made aware, researcher says ... to naturally conceived twins, those conceived through assisted reproductive ... admitted to neonatal intensive care, finds a new study. ... twins born in Western Australia between 1994 and 2000. ...
    ... (OTC Bulletin Board: MLSS), the recognized leader in advanced injection ... is scheduled to be held on Thursday, June 4, 2009 ... as of the close of business on April 10, 2009. ... of Brown, Rudnick, Berlack and Israels located at 7 Times ...
    Other Medicine News:Health News:Regulating the sugar factory in diabetes 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE 2Health News:Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 5Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 6Health News:Fertility Treatment Twins More at Risk for Hospitalizations 2Health News:Milestone Scientific to Host 2009 Annual Meeting of Stockholders on Thursday, June 4, 2009 in New York City 2
    (Date:12/14/2009)... Dec. 14 Fujirebio Diagnostics Inc., a ... of the Year by the Eastern Technology Council ... Hotel in Philadelphia on Thursday, December 3, 2009. ... the Philadelphia region,s largest technology and life sciences ... the Technology and Life Sciences Community, the awards ...
    (Date:12/14/2009)... Dec. 14 Following is a statement ... Consumer Healthcare Products Association (CHPA), regarding today,s release ... Monitoring the Future survey: ,, "Findings released today ... to the need for continued efforts to educate ... to talk to their teens about medicine abuse. ...
    (Date:12/14/2009)... Cardinal Health today announced that executives of the company ... Goldman Sachs CEO Unplugged Conference on Jan. ... Center in New York. 28th Annual J.P. ... EST at the Westin St. Francis Hotel in San ... discuss Cardinal Health,s diverse products and services, company performance ...
    Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Cardinal Health Executives to Speak at Two Investor Events in January 2Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 1Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 2Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 1Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 2New Hope for Brain Spinal Cord Injuries 63150 1New Hope for Brain Spinal Cord Injuries 63150 2
    ... 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: IZP). As announced ... the Phase 2b CAPSICS study with,IPL512,602 showed ... received drug or placebo. However, the placebo,response ... number of,the end-points, which prompted an examination ...
    ... at,the Stanford University School of Medicine say they ... that an antidepressant,which previously showed promise in treating ... result in a sustained benefit,for the patients who ... prescribed,antidepressant sold under the brand name Lexapro. In ...
    Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Medicine Products: